Harbin Pharmaceutical Group Co., Ltd. (600664.SS) SHH

3.76

+0.04(+1.08%)

Updated at October 22 02:07PM

Currency In CNY

Valuation

Market Cap10.39B
Enterprise Value8.38B
P/E Ratio18.36
PEG Ratio-0.95
Price/Sales Ratio0.59
Price/Book Ratio1.78
Enterprise/Revenue0.47
Enterprise/EBITDA9.24

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.03
Operating Margin0.05

Management Effectiveness

Return On Assets0.04
Return On Equity0.1

Income Statement

Revenue16.18B
Revenue/Share6.07
Gross Profit4.52B
EBITDA1.07B
Net Income628.85M
Diluted EPS0.25

Balance Sheet

Total Cash3.05B
Total Cash/Share1.15
Total Debt1.17B
Total Debt/Equity0.21
Current Ratio1.44
Book Value Per Share2.39

Price History

52-Week Change2.73
52-Week High4.97
52-Week Low3.06
Moving Average 50 Days3.71
Moving Average 200 Days3.73

Statistics

Average Volume44.07M
Shares Outstanding2.52B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.08
Last Split Factor13:10
Last Split DateApril 06, 2016